In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
UroGen Pharma Ltd (NASDAQ: URGN) closed the day trading at $7.31 down -25.79% from the previous closing price of $9.85. In other words, the price has decreased by -$25.79 from its previous closing price. On the day, 9.58 million shares were traded.
Ratios:
For a better understanding of URGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.47 and its Current Ratio is at 5.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on April 16, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $23.
On August 22, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $40.Guggenheim initiated its Buy rating on August 22, 2024, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 31 ’25 when Schoenberg Mark sold 4,551 shares for $11.14 per share. The transaction valued at 50,698 led to the insider holds 145,666 shares of the business.
Smith Jason Drew sold 7,379 shares of URGN for $82,202 on Jan 31 ’25. The General Counsel now owns 26,468 shares after completing the transaction at $11.14 per share. On Sep 09 ’24, another insider, Schoenberg Mark, who serves as the Chief Medical Officer of the company, sold 859 shares for $13.08 each. As a result, the insider received 11,236 and left with 145,091 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.67.
Stock Price History:
Over the past 52 weeks, URGN has reached a high of $20.70, while it has fallen to a 52-week low of $8.94. The 50-Day Moving Average of the stock is -31.10%, while the 200-Day Moving Average is calculated to be -37.83%.
Shares Statistics:
A total of 46.10M shares are outstanding, with a floating share count of 38.22M. Insiders hold about 17.09% of the company’s shares, while institutions hold 85.40% stake in the company.
